Bath & Body Works, Inc. (NYSE:BBWI) Shares Sold by Barclays PLC

Barclays PLC lowered its stake in shares of Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 18.3% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 481,490 shares of the company's stock after selling 108,070 shares during the quarter. Barclays PLC owned approximately 0.22% of Bath & Body Works worth $15,371,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Nomura Asset Management Co. Ltd. increased its stake in shares of Bath & Body Works by 30.6% in the 3rd quarter. Nomura Asset Management Co. Ltd. now owns 137,610 shares of the company's stock valued at $4,393,000 after buying an additional 32,233 shares during the period. iA Global Asset Management Inc. boosted its holdings in Bath & Body Works by 1,078.2% in the third quarter. iA Global Asset Management Inc. now owns 49,331 shares of the company's stock valued at $1,575,000 after acquiring an additional 45,144 shares during the last quarter. Wellington Management Group LLP bought a new position in Bath & Body Works in the third quarter valued at about $8,129,000. Weiss Asset Management LP increased its position in Bath & Body Works by 29.0% in the third quarter. Weiss Asset Management LP now owns 377,969 shares of the company's stock worth $12,065,000 after purchasing an additional 84,873 shares during the period. Finally, Quantinno Capital Management LP raised its holdings in Bath & Body Works by 31.2% during the 3rd quarter. Quantinno Capital Management LP now owns 56,661 shares of the company's stock worth $1,809,000 after purchasing an additional 13,485 shares during the last quarter. Institutional investors and hedge funds own 95.14% of the company's stock.

Bath & Body Works Stock Up 1.1 %

Shares of BBWI stock traded up $0.42 on Monday, hitting $38.64. The company had a trading volume of 4,863,334 shares, compared to its average volume of 4,020,750. The firm has a market cap of $8.37 billion, a P/E ratio of 9.42, a price-to-earnings-growth ratio of 1.44 and a beta of 1.83. Bath & Body Works, Inc. has a twelve month low of $26.20 and a twelve month high of $52.99. The company has a 50-day moving average price of $32.76 and a 200-day moving average price of $34.50.

Bath & Body Works (NYSE:BBWI - Get Free Report) last posted its quarterly earnings results on Monday, November 25th. The company reported $0.49 earnings per share for the quarter, topping analysts' consensus estimates of $0.46 by $0.03. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The firm had revenue of $1.61 billion for the quarter, compared to analyst estimates of $1.58 billion. During the same period in the previous year, the business posted $0.48 earnings per share. Bath & Body Works's quarterly revenue was up 3.1% on a year-over-year basis. Equities research analysts expect that Bath & Body Works, Inc. will post 3.26 EPS for the current year.

Bath & Body Works Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, December 6th. Investors of record on Friday, November 22nd were paid a dividend of $0.20 per share. The ex-dividend date was Friday, November 22nd. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.07%. Bath & Body Works's payout ratio is currently 19.51%.

Wall Street Analyst Weigh In

Several research firms have weighed in on BBWI. Raymond James cut their target price on Bath & Body Works from $51.00 to $42.00 and set an "outperform" rating on the stock in a research note on Thursday, August 29th. Evercore ISI decreased their price target on shares of Bath & Body Works from $45.00 to $35.00 and set an "in-line" rating for the company in a report on Wednesday, August 28th. Bank of America dropped their price objective on Bath & Body Works from $54.00 to $45.00 and set a "buy" rating on the stock in a research note on Thursday, August 29th. Robert W. Baird decreased their target price on Bath & Body Works from $54.00 to $45.00 and set an "outperform" rating for the company in a research note on Thursday, August 29th. Finally, The Goldman Sachs Group decreased their price objective on Bath & Body Works from $60.00 to $49.00 and set a "buy" rating for the company in a research report on Thursday, August 29th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and nine have given a buy rating to the company. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $42.50.

Insider Buying and Selling at Bath & Body Works

In other news, CEO Gina Boswell bought 6,000 shares of the firm's stock in a transaction on Wednesday, October 9th. The shares were bought at an average cost of $29.64 per share, for a total transaction of $177,840.00. Following the completion of the transaction, the chief executive officer now owns 242,987 shares in the company, valued at $7,202,134.68. This trade represents a 2.53 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 0.27% of the stock is owned by insiders.

Bath & Body Works Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.